Strand Life Sciences Acquires India Diagnostics Business from Quest Diagnostics

150 150 Strand Life Sciences

October 6, 2018 | Bangalore Strand Life Sciences announced an agreement to acquire the India medical diagnostics business of Quest Diagnostics, the world’s leading…

read more

High Prevalence of Hereditary Breast and/or Ovarian Cancer Among Patients in India

150 150 Strand Life Sciences

A study conducted by Strand Life Sciences shows that in the Indian population, there is a high prevalence of germline mutations in the BRCA1, BRCA2, TP53 and PALB2 genes March…

read more

Strand Life Sciences Closes Financing Led By Quadria Capital

150 150 Maria Kammerer

February 8, 2018 | Bangalore Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund…

read more

Triesta Unit of HCG to Combine with Strand Life Sciences

150 150 Strand Life Sciences

Strategic initiative creates integrated platform dedicated to next generation precision medicine   January 4, 2018 | Bengaluru, India Healthcare Global Enterprises, Ltd. (HCG:NSE) today…

read more

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and

understand our Cookie Policy , Privacy Policy and our Terms of Service.